The purpose of our study was to characterize LOX, BMP1 and HIF1A expression by real-time PCR in astrocytomas with WHO grades I to IV compared to non-neoplastic brain tissue. This evidence concerns the gene BMP1 and astrocytoma (excluding glioblastoma).